Pfizer Rises After Ranbaxy Delays Generic Lipitor (Update1) - Bloomberg

Pfizer Rises After Ranbaxy Delays Generic Lipitor (Update1) Bloomberg - 5 hours ago Pfizer sued Ranbaxy again in March, this time over patents expiring in 2016 related to the process of making atorvastatin, the active ingredient in Lipitor. ... Pfizer, Ranbaxy settle Lipitor patent dispute Forbes Pfizer, Ranbaxy Reach Lipitor Deal Wall Street Journal Ranbaxy and Pfizer agree Lipitor deal Times Online Forbes - Forbes all 200 news articles

Source: http://news.google.com/news/url?sa=T&ct=us/9-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601091%26sid%3DaNVOCPHu9pyE%26refer%3Dindia&cid=1222887562&ei=F4NZSJOmMYLM8ASz8oSLCQ&usg=AFQjCNHMnAZLeuAfdqOXT3sD4sFN_QL82Q